comparemela.com

Latest Breaking News On - Remus pharmaceuticals - Page 1 : comparemela.com

Ahead of Market: 10 things that will decide D-Street action on Wednesday

Benchmark equity indices recovered to close flat on Tuesday, with gains in metal stocks offsetting declines in other sectors following top consumer China s property-support measures.

Remus Pharma zooms 20% to life high after declaring bonus issue of shares

SME listed stocks are seen outperforming the key benchmark indices in CY24 even after SEBI cautioned about possibilities of some froth in small caps and SME market segment.

2023 in Review: 62 of 176 SMEs listed this year have delivered multibagger returns; details here

234 companies have raised funds from Indian markets so far in 2023, with a significant portion of 176 companies falling within the SME category. In comparison, CY22 witnessed 103 SMEs entering the market; the number was 52 in 2021, 31 in 2020, and 31 in 2019.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.